Art. 6 Directive (EU) 1989/105

In forcesince 21 Dec 1988cited 68×

The following provisions shall apply if a medicinal product is covered by the national health insurance system only after the competent authorities have decided to include the medicinal product concerned in a positive list of medicinal products covered by the national health insurance system.

1.

Member States shall ensure that a decision on an application submitted, in accordance with the requirements laid down in the Member State concerned, by the holder of a marketing authorization to include a medicinal product in the list of medicinal products covered by the health insurance systems is adopted and communicated to the applicant within 90 days of its receipt. Where an application under this Article may be made before the competent authorities have agreed the price to be charged for the product pursuant to Article 2, or where a decision on the price of a medicinal product and a decision on its inclusion within the list of products covered by the health insurance system are taken after a single administrative procedure, the time limit shall be extended for a further 90 days. The applicant shall furnish the competent authorities with adequate information. If the information supporting the application is inadequate, the time limit shall be suspended and the competent authorities shall forthwith notify the applicant of what detailed additional information is required.

Where a Member State does not permit an application to be made under this Article before the competent authorities have agreed the price to be charged for the product pursuant to Article 2, the Member State concerned shall ensure that the overall period of time taken by the two procedures does not exceed 180 days. This time limit may be extended in accordance with Article 2 or suspended in accordance with the provisions of the preceding subparagraph.

2.

Any decision not to include a medicinal product in the list of products covered by the health insurance system shall contain a statement of reasons based upon objective and verifiable criteria, including, if appropriate, any expert opinions or recommendations on which the decision is based. In addition, the applicant shall be informed of the remedies available to him under the laws in force and of the time limits allowed for applying for such remedies.

3.

Before the date referred to in Article 11 (1), Member States shall publish in an appropriate publication and communicate to the Commission the criteria which are to be taken into account by the competent authorities in deciding whether or not to include medicinal products on the lists.

4.

Within one year of the date referred to in in Article 11(1), Member States shall publish in an appropriate publication and communicate to the Commission a complete list of the products covered by their health insurance system, together with their prices fixed by the national competent authorities. This information shall be updated at least once every year.

5.

Any decision to exclude a product from the list of products covered by the health insurance system shall contain a statement of reasons based on objective and verifiable criteria. Such decisions, including, if appropriate, any expert opinions or recommendations on which the decisions are based, shall be communicated to the person responsible, who shall be informed of the remedies available to him under the laws in force and the time limits allowed for applying for such remedies.

6.

Any decision to exclude a category of medicinal products from the list of products covered by the health insurance system shall contain a statement of reasons based on objective and verifiable criteria and be published in an appropriate publication.

The 10 that are cited most themselves, of 68.

  • Judgment of the Court (Eighth Chamber) of 16 April 2015. LFB Biomédicaments SA and Others v Ministre des Finances et des Comptes publics andDecisioninterprets

    По изложените съображения Съдът (осми състав) реши: Член 6 от Директива 89/105/ЕИО на Съвета от 21 декември 1988 година относно …

    16 Apr 2015 · 62014CJ0271

  • Judgment of the Court (Sixth Chamber) of 12 June 2003. Commission of the European Communities v République de Finlande.Decision

    By application lodged at the Court Registry on 8 June 2000, the Commission of the European Communities brought an action under Article 226 EC for a declaration that, by not adopting the laws, regulations and administrative provisions …

    12 Jun 2003 · 62000CJ0229

  • Judgment of the Court (Sixth Chamber) of 27 November 2001. Commission of the European Communities v Republic of Austria.Decision

    On the latter point it is sufficient to state that the action brought by the Commission in no way calls in question the method of financing or the structure of the social security system but seeks solely to secure observance by the …

    27 Nov 2001 · 61999CJ0424

  • Judgment of the Court (Fifth Chamber) of 26 October 2006. G. Pohl-Boskamp GmbH & Co. KG v Gemeinsamer Bundesausschuss.Decision

    This reference for a preliminary ruling concerns the interpretation of Article 6 of Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and …

    26 Oct 2006 · 62005CJ0317

  • Judgment of the Court (Second Chamber) of 20 January 2005. Glaxosmithkline SA v Belgian State.Decision

    … It is for the Member States to determine whether the fact that the time-limit laid down in the first subparagraph of Article 6(1) of Directive 89/105 is exceeded precludes the competent authorities from formally adopting a new decision …

    20 Jan 2005 · 62003CJ0296

  • Judgment of the Court (Second Chamber) of 20 January 2005. Merck, Sharp & Dohme BV v Belgian State.Decision

    Article 6 of the Directive provides: ‘The following provisions shall apply if a medicinal product is covered by the national health insurance system only after the competent authorities have decided to include the medicinal product …

    20 Jan 2005 · 62003CJ0245

  • BSG, Urteil vom 14. Mai 2014 - B 6 KA 21/13 RDecision

    14 May 2014 · KSRE126641519

  • Judgment of the Court (Eighth Chamber) of 17 July 2008. Commission of the European Communities v Republic of Austria.Decision

    17 Jul 2008 · 62007CJ0311

  • Raad van State, 26-02-2025, 202303829/2/A2Decision

    … Volgens Recordati zou dit voortvloeien uit art. 6 Richtlijn 89/105/EEG, en het daarin geïmpliceerde vereiste van effectieve (doeltreffende) rechtsbescherming, alsmede uit de rechtspraak van het Hof van Justitie over deze specifieke …

    26 Feb 2025 · ECLI:NL:RVS:2025:764

  • Opinion of Mr Advocate General Tizzano delivered on 30 September 2004. Merck, Sharp & Dohme BV v Belgian State.Decision

    30 Sep 2004 · 62003CC0245